Clinical Trial Update: PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Ingenol Mebutate Gel (PEP005) for superficial basal cell carcinoma on the trunk or extremities. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma Superficial

Drugs mentioned

• PEP005 Gel (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Superficial Basal Cell Carcinoma | Phase 2 | Status: COMPLETED